Full Length Research Paper
References
|
Albert MJ, Faruque AS, Faruque SM, Sack RB, and Mahalanabis D (1999). Case-control study of enteropathogens associated with childhood diarrhea in Dhaka, Bangladesh. J. Clin. Microbiol. 37(11): 3458-64. Pubmed |
||||
|
Avenda-o P, Matson DO, Long J, Whitney S, Matson CC, Pickering LK (1993). Cost associated with office visits for diarrhea in infants and toddlers. Pediatr. Infect. Dis. J. 12: 897-902. Crossref |
||||
|
Blaser MJ, Wells JG, Feldman RA, Pollard RA, Allen JR (1982). Campylobacter enteritis I the United States: a multicenter study. Ann. Intern. Med. 98: 360-365. Crossref |
||||
|
Burnens AP, Heitz M, Brodard I, Nicolet J (1996). Sequential development of resistance to Fluoroquinolones and erythromycin in an isolate of Campylobacter jejuni. Zentralbl. Bakteriol. 283(3): 314-21. Crossref |
||||
|
Centers for Disease Control and Prevention (CDC) (2003). Preliminary FoodNet data on the incidence of foodborne illness- selected site, United States 2002. MMWR Morb. Mortal. Wkly. Rep. 52(15): 340-343. Pubmed |
||||
| Clinical and Laboratory Standards Institute, CLSI (2004). Quality Control for Commercially Prepared Microbiological Culture Media; Approved Standard¬-Third Edition. 24(19):M22-A3. | ||||
| Clinical and Laboratory Standards Institute, CLSI (2010). Methods for Antimicrobial Dilution and Disk susceptibility testing of Infrequently Isolated or Fastidious Bacteria; Proposed Guideline. M45-(26):25. | ||||
|
Dennehy PH (2005). Acute Diarrheal Disease in children: Epidemiology, Prevention, and treatment. Infect. Dis. Clin. North Am. 19(3): 585-602. Crossref |
||||
|
Engberg J, Aarestrup FM, Taylor DE, Gerner-Smidt P, and Nachamkin I (2001). Quinolone and macrolide resistance in Campylobacter jejuni and C. coli resistance mechanisms and trends in human isolates. Emerg. Infect. Dis. 7:24-34. Crossref |
||||
|
Gaudreau C, Gilbert H (2003). Antimicrobial resistance of Campylobacter jejuni subsp. Jejuni strains isolated from humans in 1998 to 2001 in Montereal, Canada. Antrimicrob. Agents Chemother. 47: 2027-2029. Crossref |
||||
|
Gibreel A, Kos VN, Keelan M, Trieber CA, Levesque S, Michaud S (2005). Macrolide resistance in Campylobacter jejuni and "Campylobacter coli; molecular mechanism and stability of the resistance phenotype. Antimicrob. Agents Chemother. 49(7): 2753-9. Crossref |
||||
|
Glass RI, Kilgore PE, Holman RC, Jin S, Smith JC, Woods PA, et al (1996). The epidemiology of rotavirus diarrhea in the United States: Surveillance and estimates of disease burden. J. Infect. Dis. 174(1): S5-11. Crossref |
||||
|
Guerrant DI, Moore SR, Lima AA, Patrick PD, Schorling JB, Guerrant RL (1999). Association of early childhood diarrhea and cryptosporidiosis with impaired Physical fitness and cognitive function 4-7 years later in a poor urban community in Northeast Brazil. Am. J. Trop. Med. Hyg. 61(5): 707-713. Pubmed |
||||
|
Guerrant RL, Hughes JM, Lima NL, Grane J (1990). Diarrhea in developed and developing countries magnitude, special settings, and etiologies. Rev. Infect. Dis. 12(1): S41-50. Crossref |
||||
| Hardy AM, Liarson DR, Morrow AL (1994). Costs associated with gastrointestinal tract illness among children attending day-care center in Houston, Texas. Peadiatrics 94(6): 1091 -1093. | ||||
|
Holmes SJ, Marrow AL, Pickering LK (1996). Child care practices: Effects of social change on epidemiology of infectious diseases and antibiotic resistance. Epidemiol. Rev. 18: 10-28. Crossref |
||||
|
Ishihara K, Kira T, Ogikubo K, Morioka A, Kojima A, Kijima-Tanaka M (2004). Antimicrobial susceptibilities of Campylobacter isolated from food-producing animals on farms (1999-2001): results from the Japanese Veterinary antimicrobial Resistance Monitoring Program. Int. J. Antimicrob. Agents 24(3):261-267. Crossref |
||||
|
Koopman JS, Turkish VJ, Monto AS, Gouvea V, Srivastava S, Isaacson RE (1984). Patterns and etiology of diarrhea in three clinical settings. Am. J. Epidemiol. 119(1): 114-23. Pubmed |
||||
|
Kosek M, Bern C, Guerrant RL (2003). The global burden of diarrheal disease as estimated from studies published between 1992 and 2000. Bull. World Health Organ. 81:197-204. Pubmed |
||||
|
Kotloff KL, Nataro JP, Blackwelder BC, Nasrin D, Farag TH, Panchalingam S, et al (2013). Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study. Lancet 382: 209-22. Crossref |
||||
| Kumar SG, Subitha L (2012). Diarrhoeal diseases in developing countries: a situational analysis. Kathmandu Univ. Med. J. (KUMJ). 10(38): 83-88. | ||||
|
Li CC, Chiu CH, Wu JL, Huang YC, Lin TY (1998). Antimicrobial susceptibilities of Campylobacter jejuni and coli by using E-test in Taiwan. Scand. J. Infect. Dis. 30(1): 39-42. Crossref |
||||
|
Luber P, Wagner J, Hahn H, Bartelt E (2003). Antimicrobial resistance in Campylobater jejuni and Campylobacter coli strains isolated in 1991 and 2001-2002 from poultry and humans in Berlin, Germany. Antimicrob. Agents Chemother. 47(12): 2825-30. Crossref |
||||
|
Mastson DO, Estes MK (1990). Impact of rotavirus infection at large pediatric hospital. J. Infect. Dis. 162: 598-604. Crossref |
||||
|
Mikhail IA, Fox E, Haberberger RL Jr, Ahmed MH, Abbatte EA (1990). Epidemiology of bacterial pathogens associated with diarrhea in Djibouti. J. Clin. Microbiol. 28(5): 956-61. Pubmed |
||||
|
Moore JE, Madden RH, Kerr JR, Wilson TS, Murphy PG (1996). Erythromycin-resistant thermophilic Campylobacter species isolated from pigs. Vet. Rec. 138 (13): 306-7. Crossref |
||||
| Osterlund A, Hermann M, Kahlmeter G (2003). Antibiotic resistance among Campylobacter jejuni coli strains acquired in Sweden and abroad: a longitudinal study. Scand. J. Infect. Dis. 35: 478-81. Piekering LK (1990). Bacterial and parasitic enteropathogens in day case. Semin. Pediatr. Infect. Dis. 1: 263-269. | ||||
|
Smith KE, Besser JM, Hedberg CW, Leano FT, Bender JB, Wicklund JH (1999). Quinolone-resistant Campylobacter jejuni infections in Minnesota, 1992-1998. Investigation Team. N. Engl. J. Med. 340(20): 1525-1532. Crossref |
||||
|
Smith SI, Sansa TI, Coker AO (1999). Antibiotic susceptibility patterns and β-lactamase production of animal and human isolates of Campylobacter in lagos, Nigeria. Z. Naturforsch C. 54: 583-6. Pubmed |
||||
|
Sojo A, Elorz J, Eizaguirre J, Lafuente P, Rubio MC, Gutiérrez C, Vitoria JC (1982). Gastroenteritis caused by Campylobacter jejuni in childhood. An. Esp. Pediatr. 17(1): 34-39. Pubmed |
||||
|
Somily AM, Sayyed SB, Habib HA, Al-Khattaf AS, Al-Otabi WE, Shakoor Z, Kambal AM (2012). Salmonella isolates' serotypes and susceptibility to commonly used drugs at a tertiary care hospital in Riyadh, Saudi Arabia. J. Infect. Dev. Ctries. 6(6):478-482. Crossref |
||||
| Steinbigel NH (1990). Erythromycin, Lincomycin and Clindamycin. In: Mandell GL, Douglas RG, Bennett JE, editors. Principles practice of infectious diseases, 3rd. New York: Churchill Livingstone. p. 309. | ||||
|
Tucker AW, Haddix AC, Bresee JS, Holman RC, Parashar UD, Glass RI (1998). Cost-effectiveness analysis of rotavirus immunization program for the United States. JAMA 279: 1371-6. Crossref |
||||
| Wanke CA, Calderwood SB, Bloom A (2013a). Approach to the adult with acute in developed countries. Literature review current through: Jan 2013. This topic last updated: Jun 19, 2013. www.uptodate.com. | ||||
| Wanke CA, Calderwood SB, Bloom A (2013b). Epidemiology and causes of acute diarrhea in developed countries. Literature review current through: Sep 2013. This topic last updated: Aug 15, 2013. www.uptodate.com. | ||||
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
